Form: SB-2/A

Optional form for registration of securities to be sold to the public by small business issuers

July 25, 1996

CONSENT OF INDEPENDENT ACCOUNTANTS

Published on July 25, 1996





EXHIBIT 24.3


CONSENT OF INDEPENDENT ACCOUNTANTS


We consent to inclusion in this Post-Effective Amendment No. 1 to the
Registration Statement on Form SB-2 of our report dated February 2, 1996 on our
audits of the financial statements of Cytoclonal Pharmaceutics Inc. We also
consent to the reference of our firm under the captions "Experts" and "Selected
Financial Data" in the Prospectus.



New York, NY
July 23, 1996